3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
54
Lung Neoplasms
46
Neoplasm Metastasis
36
Carcinoma, Non-Small-Cell Lung
36
Breast Neoplasms
27
Multiple Myeloma
26
Glioma
24
Carcinoma, Renal Cell
22
Pancreatic Neoplasms
21
Melanoma
21
Glioblastoma
21
Lymphoma, Large B-Cell, Diffuse
20
Squamous Cell Carcinoma of Head and Neck
19
Ovarian Neoplasms
19
Urinary Bladder Neoplasms
18
Lymphoma
18
Colorectal Neoplasms
18
Triple Negative Breast Neoplasms
15
Oropharyngeal Neoplasms
15
Mouth Neoplasms
15
Brain Neoplasms
15
Fallopian Tube Neoplasms
13
Carcinoma, Hepatocellular
13
Carcinoma
13
Laryngeal Neoplasms
12
Astrocytoma
12
Lymphoma, Follicular
11
Leukemia, Myeloid, Acute
11
Sarcoma
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Interventions
belzutifan
3
palbociclib
1
lenvatinib
1
gallium Ga 68 dotatate
1
cabozantinib
1
Nivolumab
1
Everolimus
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
von Hippel-Lindau Disease
×
Magnetic Resonance Spectroscopy
×
90 days
×
Clear all
No trials found.